DK0882021T3 - Nye phenanthridiner - Google Patents

Nye phenanthridiner

Info

Publication number: DK0882021T3
Authority: DK; Denmark
Prior art keywords: new; phenanthridines; compounds; formula; description
Prior art date: 1996-01-31

Application number

DK97904354T

Other languages

English (en)

Inventor

Hermann Amschler

Wolf-Ruediger Ulrich

Thomas Baer

Thomas Martin

Hildegard Boss

Beate Schmidt

Dieter Flockerzi

Christian Schudt

Armin Hatzelmann

Rolf Beume

Dietrich Haefner

Hans-Peter Kley

Karl-Josef Goebel

Beate Gutterer

Original Assignee

Altana Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-31

Filing date

1997-01-30

Publication date

2003-06-23

1996-01-31 Priority claimed from DE19603321A external-priority patent/DE19603321A1/de

1997-01-30 Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag

2003-06-23 Application granted granted Critical

2003-06-23 Publication of DK0882021T3 publication Critical patent/DK0882021T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)

DK97904354T 1996-01-31 1997-01-30 Nye phenanthridiner DK0882021T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19603321A DE19603321A1 (de)	1996-01-31	1996-01-31	Neue Phenanthridine
EP96101791		1996-02-08
PCT/EP1997/000402 WO1997028131A1 (de)	1996-01-31	1997-01-30	Neue phenanthridine

Publications (1)

Publication Number	Publication Date
DK0882021T3 true DK0882021T3 (da)	2003-06-23

Family

ID=26022482

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97904354T DK0882021T3 (da)	1996-01-31	1997-01-30	Nye phenanthridiner

Country Status (19)

Country	Link
US (1)	US6191138B1 (da)
EP (1)	EP0882021B1 (da)
JP (1)	JP4138003B2 (da)
KR (1)	KR100454781B1 (da)
AT (1)	ATE233735T1 (da)
BR (1)	BR9707233A (da)
CA (1)	CA2245142C (da)
CY (1)	CY2473B1 (da)
CZ (1)	CZ289340B6 (da)
DE (1)	DE59709437D1 (da)
DK (1)	DK0882021T3 (da)
EA (1)	EA001205B1 (da)
EE (1)	EE03523B1 (da)
ES (1)	ES2194180T3 (da)
HU (1)	HU221380B1 (da)
PT (1)	PT882021E (da)
SI (1)	SI0882021T1 (da)
UA (1)	UA48216C2 (da)
WO (1)	WO1997028131A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2194180T3 (es) *	1996-01-31	2003-11-16	Altana Pharma Ag	Nuevas fenantridinas.
IL133825A (en) *	1997-07-25	2005-12-18	Altana Pharma Ag	Substituted 6-phenylphenanthridines, medicaments containing same and use thereof in the production of medicaments
PL190685B1 (pl) *	1997-07-25	2005-12-30	Altana Pharma Ag	Nowe pochodne tetrazolu, środek farmaceutyczny oraz zastosowanie
GB9828340D0 (en) *	1998-12-22	1999-02-17	Novartis Ag	Organic compounds
SK286946B6 (sk) *	1999-01-15	2009-08-06	Nycomed Gmbh	Fenylfenantridínové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
EP1163226B1 (en) *	1999-01-15	2007-03-14	ALTANA Pharma AG	Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
PT1147087E (pt)	1999-01-15	2005-09-30	Altana Pharma Ag	Feantridina-n-oxidos com actividade de inibicao de pde-iv
US6479505B1 (en) *	1999-01-15	2002-11-12	Altana Pharma Ag	6-arylphenanthridines with PDE-IV inhibiting activity
PT1147103E (pt)	1999-01-15	2005-08-31	Altana Pharma Ag	Fenantridina-n-oxidos com actividade inibitoria de pde-iv
TR200201317T2 (tr)	1999-08-21	2002-11-21	Byk Gulden Lomberg Chemische Fabrik Gmbh	Sinerjistik kombinasyon.
US6630483B2 (en)	2000-01-11	2003-10-07	Altana Pharma Ag	Phenanthridine-N-oxides
DK1303506T3 (da) *	2000-07-14	2005-05-30	Altana Pharma Ag	6-heteroarylphenanthridiner
WO2002006238A1 (en) *	2000-07-14	2002-01-24	Altana Pharma Ag	Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
WO2002006239A1 (en) *	2000-07-14	2002-01-24	Altana Pharma Ag	Phenanthridine n-oxides
AU2001281965A1 (en) *	2000-07-14	2002-01-30	Byk Gulden Lomberg Chemische Fabrik G.M.B.H.	Novel 6-phenylphenanthridines
CN1264574C (zh) *	2000-09-06	2006-07-19	田边制药株式会社	口服制剂
CA2437754C (en) *	2001-02-15	2010-05-18	Tanabe Seiyaku Co., Ltd.	Tablets quickly disintegrated in oral cavity
US20060116518A1 (en) *	2002-08-17	2006-06-01	Altana Pharma Ag	Novel phenanthridines
WO2004019945A1 (en) *	2002-08-29	2004-03-11	Altana Pharma Ag	3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2279215T3 (es)	2002-08-29	2007-08-16	Altana Pharma Ag	2-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
WO2004087211A2 (en)	2003-04-01	2004-10-14	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
EP1658270A1 (en) *	2003-07-31	2006-05-24	ALTANA Pharma AG	Novel 6-phenylphenantridines
US20060189641A1 (en) *	2003-07-31	2006-08-24	Beate Schmidt	Novel 6-phenlyphenanthridines
AU2004269923B2 (en) *	2003-09-05	2010-05-13	Takeda Gmbh	Use of PDE4 inhibitors for the treatment of diabetes mellitus
WO2005077906A1 (en) *	2004-02-18	2005-08-25	Altana Pharma Ag	Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors
CN1922170A (zh)	2004-03-03	2007-02-28	奥坦纳医药公司	新的羟基－6－杂芳基菲啶及其作为pde4
AR049419A1 (es) *	2004-03-03	2006-08-02	Altana Pharma Ag	Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
JP2007527899A (ja) *	2004-03-09	2007-10-04	アルタナ　ファルマ　アクチエンゲゼルシャフト	新規のイソアミド置換されたヒドロキシ−６−フェニルフェナントリジン
WO2005087744A1 (en) *	2004-03-10	2005-09-22	Altana Pharma Ag	Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
CA2558532A1 (en) *	2004-03-10	2005-09-15	Altana Pharma Ag	Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
NZ549254A (en) *	2004-03-10	2010-06-25	Nycomed Gmbh	Amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
US7589205B2 (en) *	2004-09-08	2009-09-15	Nycomed Gmbh	3-thia-10-aza-phenanthrene derivatives
EP1797098B1 (en) *	2004-09-08	2011-05-04	Nycomed GmbH	3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors
US7411093B2 (en)	2004-12-20	2008-08-12	Hoffman-La Roche Inc.	Aminocycloalkanes as DPP-IV inhibitors
WO2006092422A1 (en)	2005-03-02	2006-09-08	Nycomed Gmbh	Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
EA015382B1 (ru)	2005-03-08	2011-08-30	Никомед Гмбх	Применение рофлумиласта для лечения сахарного диабета типа 2
AU2006221957A1 (en) *	2005-03-09	2006-09-14	Nycomed Gmbh	Amido-substituted 6-phenylphenanthridines
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
US7678363B2 (en)	2005-08-26	2010-03-16	Braincells Inc	Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
JP2009512711A (ja)	2005-10-21	2009-03-26	ブレインセルス，インコーポレイティド	Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
CA2643199A1 (en) *	2006-03-08	2007-09-13	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
EP2377531A2 (en)	2006-05-09	2011-10-19	Braincells, Inc.	Neurogenesis by modulating angiotensin
US20100009983A1 (en) *	2006-05-09	2010-01-14	Braincells, Inc.	5 ht receptor mediated neurogenesis
JP2009536667A (ja) *	2006-05-09	2009-10-15	ブレインセルス，インコーポレイティド	５ｈｔ受容体介在性の神経新生
JP2010502722A (ja) *	2006-09-08	2010-01-28	ブレインセルス，インコーポレイティド	４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
AU2007299920A1 (en) *	2006-09-19	2008-03-27	Braincells, Inc.	PPAR Mediated Modulation of Neurogenesis
BRPI0811639A2 (pt) *	2007-05-31	2014-09-30	Sepracor Inc	Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
KR101067069B1 (ko) *	2009-03-09	2011-09-22	부경대학교 산학협력단	트리플루오로아세트산을 이용한 페난트리딘 유도체의 제조방법
CN102179655B (zh) *	2011-06-01	2013-09-04	柳州市久日工程机械有限公司	履带梁拼搭气动工装
US20150119399A1 (en)	2012-01-10	2015-04-30	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use
JP7234470B2 (ja)	2015-10-30	2023-03-08	トーヨーカネツ株式会社	立体自動倉庫

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE786031A (fr) *	1971-07-08	1973-01-08	Rhone Poulenc Sa	Nouveaux derives de la phenanthridine, leur preparation et les compositions medicinales qui les contiennent
US4309545A (en) *	1980-07-28	1982-01-05	Pfizer Inc.	Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
ES2194180T3 (es) *	1996-01-31	2003-11-16	Altana Pharma Ag	Nuevas fenantridinas.

1997
- 1997-01-30 ES ES97904354T patent/ES2194180T3/es not_active Expired - Lifetime
- 1997-01-30 AT AT97904354T patent/ATE233735T1/de not_active IP Right Cessation
- 1997-01-30 HU HU9900666A patent/HU221380B1/hu not_active IP Right Cessation
- 1997-01-30 WO PCT/EP1997/000402 patent/WO1997028131A1/de active IP Right Grant
- 1997-01-30 CZ CZ19982414A patent/CZ289340B6/cs not_active IP Right Cessation
- 1997-01-30 EA EA199800667A patent/EA001205B1/ru not_active IP Right Cessation
- 1997-01-30 KR KR10-1998-0705865A patent/KR100454781B1/ko not_active Expired - Fee Related
- 1997-01-30 UA UA98084553A patent/UA48216C2/uk unknown
- 1997-01-30 CA CA002245142A patent/CA2245142C/en not_active Expired - Fee Related
- 1997-01-30 DE DE59709437T patent/DE59709437D1/de not_active Expired - Fee Related
- 1997-01-30 EP EP97904354A patent/EP0882021B1/de not_active Expired - Lifetime
- 1997-01-30 SI SI9730530T patent/SI0882021T1/xx unknown
- 1997-01-30 US US09/117,507 patent/US6191138B1/en not_active Expired - Fee Related
- 1997-01-30 PT PT97904354T patent/PT882021E/pt unknown
- 1997-01-30 DK DK97904354T patent/DK0882021T3/da active
- 1997-01-30 EE EE9800223A patent/EE03523B1/xx not_active IP Right Cessation
- 1997-01-30 JP JP52714097A patent/JP4138003B2/ja not_active Expired - Fee Related
- 1997-01-30 BR BR9707233A patent/BR9707233A/pt not_active IP Right Cessation
2004
- 2004-08-24 CY CY0400065A patent/CY2473B1/xx unknown

Also Published As

Publication number	Publication date
HUP9900666A3 (en)	2000-04-28
EE03523B1 (et)	2001-10-15
CZ241498A3 (cs)	1998-12-16
KR100454781B1 (ko)	2005-04-08
DE59709437D1 (de)	2003-04-10
BR9707233A (pt)	1999-07-20
SI0882021T1 (en)	2003-10-31
KR19990082143A (ko)	1999-11-15
EA001205B1 (ru)	2000-12-25
CA2245142A1 (en)	1997-08-07
HUP9900666A2 (hu)	1999-06-28
EA199800667A1 (ru)	1999-02-25
JP2000503996A (ja)	2000-04-04
EP0882021B1 (de)	2003-03-05
US6191138B1 (en)	2001-02-20
UA48216C2 (uk)	2002-08-15
HU221380B1 (en)	2002-09-28
EP0882021A1 (de)	1998-12-09
WO1997028131A1 (de)	1997-08-07
CZ289340B6 (cs)	2002-01-16
CY2473B1 (en)	2005-06-03
PT882021E (pt)	2003-07-31
ATE233735T1 (de)	2003-03-15
JP4138003B2 (ja)	2008-08-20
ES2194180T3 (es)	2003-11-16
CA2245142C (en)	2004-11-30
EE9800223A (et)	1998-12-15

Publication	Publication Date	Title
DK0882021T3 (da)	2003-06-23	Nye phenanthridiner
DK0889886T3 (da)	2003-01-20	Hidtil ukendte, i 6-stilling substituerede phenanthridiner
EA200100731A1 (ru)	2002-02-28	Фенилфенантридины с ингибирующей фдэ-4 активностью
DK0998460T3 (da)	2004-07-05	Hidtil ukendte tetrazolderivater
ES2189235T3 (es)	2003-07-01	6-fenilfenantridinas sustituidas.
ID22042A (id)	1999-08-26	Benzonaftiridin sebagai pengobatan cabang tenggorokan
TR200002248T2 (tr)	2000-12-21	Yeni dihidroksiheksanoik asit türevleri
DE60019894D1 (de)	2005-06-09	Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
DE60025327D1 (de)	2006-03-30	6-arylphenanthridine mit pde-iv hemmender wirkung
ATE295352T1 (de)	2005-05-15	Phenanthridine-n-oxide mit pde-iv hemmender wirkung
NZ331374A (en)	2000-01-28	Phenanthridine compounds and pharmaceutical compositions thereof
PT937075E (pt)	2004-05-31	Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese
AU758194C (en)	2004-04-08	Novel benzimidazoles and benzoxazoles